SNHG3 and urinary bladder cancer: Moreover, the OS (Figure 1E) and DFS (Figure 1F) in the SNHG3 overexpression group was remarkably lower in contrast to that in the SNHG3 down-regulation group, indicating that SNHG3 could be applied as a prognostic indicator for bladder cancer.